StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.23−0.03 (-10.27%)

Close on Nov 17, 2026Market cap $3.59MP/E –Yield –

Traws Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Traws Pharma's price to book ratio was 3.0× on Apr 30, 2020, against 3.4× a year earlier. Over the last 5 years it ranged from 1.1× to 9.8×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Apr 30, 20203.0×−1.2
2019Apr 30, 20194.2×+3.1
2018Dec 31, 20181.1×−2.3
2017Apr 28, 20173.4×+1.8
2016Dec 30, 20161.7×−5.1
2015Dec 31, 20156.8×+4.7
2014Dec 31, 20142.0×−0.6
2013Dec 31, 20132.6×–

More Traws Pharma figures

See a number that looks wrong?